Page 15 - Return Level News Today

This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.

This gene-editing pioneer could make history this week. But shareholders should remain focused on the long term.

These two defensive dividend stocks sport compelling valuations and attractive yields.

These three low-cost funds are a low-stress way to grow richer slowly.

These elite companies make exceptional foundational investments for any portfolio.

Vici Properties lets you own a piece of the house, especially in Las Vegas.

These two healthcare stocks are proven passive income vehicles.

This real estate investment trust's 8% dividend yield makes it an intriguing choice for income investors.

These two low-cost growth ETFs could deliver spectacular returns for long-term investors.

Hercules Capital has a rich history of dividend payments and outperforming the competition.